Skip to main content
Print Save

93 5721 (Buprenorphine Hydrochloride and Naloxone Hydrochloride (Sublingual) 8 mg (base) / 2 mg (base))

Pill with imprint 93 5721 is White, Round and has been identified as Buprenorphine Hydrochloride and Naloxone Hydrochloride (Sublingual) 8 mg (base) / 2 mg (base). It is supplied by Teva Pharmaceuticals USA Inc.

Buprenorphine/naloxone is used in the treatment of opiate dependence and belongs to the drug class narcotic analgesic combinations. Risk cannot be ruled out during pregnancy. Buprenorphine/naloxone 8 mg (base) / 2 mg (base) is classified as a Schedule 3 controlled substance under the Controlled Substance Act (CSA).

Images for 93 5721

Buprenorphine hydrochloride and naloxone hydrochloride (sublingual) 8 mg (base) / 2 mg (base) 93 5721

Buprenorphine Hydrochloride and Naloxone Hydrochloride (Sublingual)

Imprint
93 5721
Strength
8 mg (base) / 2 mg (base)
Color
White
Shape
Round
Availability
Prescription only
Drug Class
Narcotic analgesic combinations
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
3 - Moderate abuse potential
Labeler / Supplier
Teva Pharmaceuticals USA Inc.
National Drug Code (NDC)
00093-5721 (Discontinued)
Inactive Ingredients
acesulfame potassium, citric acid anhydrous, corn starch, lactose monohydrate, magnesium stearate, mannitol, povidone k30, trisodium citrate dihydrate

Note: Inactive ingredients may vary.

Drug Uses Add to Drug List Print

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer